Leslie Tari - Mar 13, 2023 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Shane Ward, Attorney-in-Fact
Stock symbol
CDTX
Transactions as of
Mar 13, 2023
Transactions value $
-$11,570
Form type
4
Date filed
3/13/2023, 09:21 PM
Previous filing
Jan 27, 2023
Next filing
Mar 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Sale -$11.6K -7.56K -3.82% $1.53 190K Mar 13, 2023 Direct F1
holding CDTX Common Stock 1.48K Mar 13, 2023 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.